Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Establish the maximum tolerated dose (MTD) of study drug, with and without G-CSF.
United States: Food and Drug Administration
|Wayne State University, Karmanos Cancer Institute||Detroit, Michigan|
|Marlene and Stewart Greenebaum Cancer Center||Baltimore, Maryland 21201|